Dr. King Discusses Approaches to Lymphedema in Breast Cancer

Video

In Partnership With:

Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses approaches to treating lymphedema in patients with breast cancer.

Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses approaches to treating lymphedema in patients with breast cancer.

Investigators have been studying the effects of not removing additional lymph nodes in patient with breast cancer. Both observation and axillary radiotherapy have been proven to be effective and have lower rates of lymphedema than axillary node dissection, says King, although many providers prefer to avoid radiation, if possible.

Women who do not have additional surgery do not have to see their physician or undergo extra testing as often as those who do undergo additional surgery, as the rate of axillary recurrence is so low. These patients only require standard surveillance due to this low event rate, says King.

Related Videos
Joseph G. Jurcic, MD
Zeynep Eroglu, MD
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles